Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates cortical porosity with age

Journal of Bone and Mineral Research

Volumn 29, Issue 1, 2014, Pages 103-117

  Jilka, Robert L ^a   O'Brien, Charles A ^a   Roberson, Paula K ^a   Bonewald, Lynda F ^b   Weinstein, Robert S ^a   Manolagas, Stavros C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

aging; Apoptosis; bone formation; cortical porosity; osteoblasts; osteocytes; rankl

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN BAK; PROTEIN BAX; VASCULOTROPIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE CELL; BONE MASS; BONE MATRIX; CELL AGING; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CORTICAL BONE; HOMEOSTASIS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; POROSITY; TRABECULAR BONE;

AGING; APOPTOSIS; BONE FORMATION; CORTICAL POROSITY; OSTEOBLASTS; OSTEOCYTES; RANKL;

AGING; ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BONE DENSITY; BONE REMODELING; CALCIUM; FEMALE; FEMUR; HOMEOSTASIS; MICE; OSTEOBLASTS; OSTEOCYTES; POROSITY;

EID: 84890899395     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2007     Document Type: Article

References (60)

1. Manolagas SC., Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000; 21: 115-37.
2. Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O'Brien CA, Bellido T, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC., Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007; 282: 27285-97.
3. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC., Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998; 102: 274-82.
4. Jilka RL., Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone. 2007; 40: 1434-46.
5. Manolagas SC, Parfitt AM., What old means to bone. Trends Endocrinol Metab. 2010; 21: 369-74.
6. Bonewald LF., The amazing osteocyte. J Bone Miner Res. 2011; 26: 229-38.
7. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H., Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17: 1231-4.
8. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA., Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17: 1235-41.
9. Kennedy OD, Herman BC, Laudier DM, Majeska RJ, Sun HB, Schaffler MB., Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone. 2012; 50: 1115-22.
10. Jilka RL, Noble B, Weinstein RS., Osteocyte apoptosis. Bone. 2013; 54: 264-71.
11. Manolagas SC., From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010; 31: 266-300.
12. Hui SL, Slemenda CW, Johnston CC Jr., Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988; 81: 1804-9.
13. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N., Assessment of fracture risk. Osteoporos Int. 2005; 16: 581-9.
14. Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI, Mackie EJ, Seeman E., Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010; 375: 1729-36.
15. Nicks KM, Amin S, Atkinson EJ, Riggs BL, Melton LJ III, Khosla S., Relationship of age to bone microstructure independent of areal bone mineral density. J Bone Miner Res. 2012; 27: 637-44.
16. Bjornerem A, Ghasem-Zadeh A, Zebaze R, Bui M, Wang X, Hopper JL, Seeman E., Cortical porosity and bone loss predate menopause. J Bone Miner Res. 2012; 27: S67.
17. Bala Y, Zebaze R, Ghasem-Zadeh A, Peterson J, Amin S, Melton LJ, Khosla S, Seeman E., Osteoporosis is not enough: cortical porosity identifies women with distal forearm fractures. J Bone Miner Res. 2012; 27: S42.
18. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nunez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012; 19: 107-20.
19. Shamas-Din A, Brahmbhatt H, Leber B, Andrews DW., BH3-only proteins: Orchestrators of apoptosis. Biochim Biophys Acta. 2011; 1813: 508-20.
20. Dewson G, Ma S, Frederick P, Hockings C, Tan I, Kratina T, Kluck RM., Bax dimerizes via a symmetric BH3: groove interface during apoptosis. Cell Death Differ. 2012; 19: 661-70.
21. Takeuchi O, Fisher J, Suh H, Harada H, Malynn BA, Korsmeyer SJ., Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci U S A. 2005; 102: 11272-7.
22. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ., Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001; 292: 727-30.
23. Ruiz-Vela A, Opferman JT, Cheng ET, Korsmeyer SJ., Proapoptotic BAX and BAK control multiple initiator caspases. EMBO Rep. 2005; 6: 379-85.
24. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL., Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002; 277: 44005-12.
25. Rodda SJ, McMahon AP., Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 2006; 133: 3231-44.
26. Powell WF Jr, Barry KJ, Tulum I, Kobayashi T, Harris SE, Bringhurst FR, Pajevic PD., Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol. 2011; 209: 21-32.
27. -ΔΔCT method. Methods. 2001; 25: 402-8.
28. Paic F, Igwe JC, Nori R, Kronenberg MS, Franceschetti T, Harrington P, Kuo L, Shin DG, Rowe DW, Harris SE, Kalajzic I., Identification of differentially expressed genes between osteoblasts and osteocytes. Bone. 2009; 45: 682-92.
29. Stephens A, Stephens S, Morrison N., Internal control genes for quantitative RT-PCR expression analysis in mouse osteoblasts, osteoclasts and macrophages. BMC Res Notes. 2011; 4: 410.
30. O'Brien CA, Jilka RL, Fu Q, Stewart S, Weinstein RS, Manolagas SC., IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab. 2005; 289: E784-E93.
31. Jilka RL, Almeida M, Ambrogini E, Han L, Roberson PK, Weinstein RS, Manolagas SC., Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration. Aging Cell. 2010; 9: 851-67.
32. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML., Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res. 2007; 22: 1197-207.
33. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25: 1468-86.
34. Schneider P, Stauber M, Voide R, Stampanoni M, Donahue LR, Muller R., Ultrastructural properties in cortical bone vary greatly in two inbred strains of mice as assessed by synchrotron light based micro- and nano-CT. J Bone Miner Res. 2007; 22: 1557-70.
35. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM., Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013; 28: 2-17.
36. Barragan-Adjemian C, Nicolella D, Dusevich V, Dallas MR, Eick JD, Bonewald LF., Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone. Calcif Tissue Int. 2006; 79: 340-53.
37. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE., Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006; 38: 1310-5.
38. Almeida M, Ambrogini E, Han L, Manolagas SC, Jilka RL., Increased lipid oxidation causes oxidative stress, increased PPARγ expression and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem. 2009; 284: 27438-48.
39. Davey RA, Clarke MV, Sastra S, Skinner JP, Chiang C, Anderson PH, Zajac JD., Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual. Transgenic Res. 2012; 21: 885-93.
40. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC., Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999; 104: 439-46.
41. Halloran BP, Ferguson VL, Simske SJ, Burghardt A, Venton LL, Majumdar S., Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res. 2002; 17: 1044-50.
42. Pantschenko AG, Zhang W, Nahounou M, McCarthy MB, Stover ML, Lichtler AC, Clark SH, Gronowicz GA., Effect of osteoblast-targeted expression of Bcl-2 in bone: differential response in male and female mice. J Bone Miner Res. 2005; 20: 1414-29.
43. Moriishi T, Maruyama Z, Fukuyama R, Ito M, Miyazaki T, Kitaura H, Ohnishi H, Furuichi T, Kawai Y, Masuyama R, Komori H, Takada K, Kawaguchi H, Komori T., Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis. PLoS One. 2011; 6: e27487.
44. Weiss A, Arbell I, Steinhagen-Thiessen E, Silbermann M., Structural changes in aging bone: osteopenia in the proximal femurs of female mice. Bone. 1991; 12: 165-72.
45. Silbermann M, Weiss A, Reznick AZ, Eilam Y, Szydel N, Gershon D., Age-related trend for osteopenia in femurs of female C57BL/6 mice. Compr Gerontol A. 1987; 1: 45-51.
46. Ferguson VL, Ayers RA, Bateman TA, Simske SJ., Bone development and age-related bone loss in male C57BL/6J mice. Bone. 2003; 33: 387-98.
47. Boyde A, Compston JE, Reeve J, Bell KL, Noble BS, Jones SJ, Loveridge N., Effect of estrogen suppression on the mineralization density of iliac crest biopsies in young women as assessed by backscattered electron imaging. Bone. 1998; 22: 241-50.
48. Enlow DH., A study of the post-natal growth and remodeling of bone. Am J Anat. 1962; 110: 79-101.
49. Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL., Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts: a putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem. 2003; 278: 50259-72.
50. Wan M, Yang C, Li J, Wu X, Yuan H, Ma H, He X, Nie S, Chang C, Cao X., Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev. 2008; 22: 2968-79.
51. Kramer I, Keller H, Leupin O, Kneissel M., Does osteocytic SOST suppression mediate PTH bone anabolism?. Trends Endocrinol Metab. 2010; 21: 237-44.
52. Almeida M, Iyer S, Martin-Millan M, Bartell SM, Han L, Ambrogini E, Onal M, Xiong J, Weinstein RS, Jilka RL, O'Brien CA, Manolagas SC., Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest. 2013; 123: 394-404.
53. Jilka RL, O'Brien CA, Ali AA, Roberson PK, Weinstein RS, Manolagas SC., Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone. 2009; 44: 275-86.
54. Parfitt AM, Kleerekoper M, Villanueva AR., Increased bone age: mechanisms and consequences. In:, Christianson C, Johnsen C, Riis BJ, editors. Osteoporosis. Copenhagen: Osteopress ApS; p. 301-8. 1987.
55. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, Tsujimoto Y., Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 2004; 6: 1221-8.
56. Manolagas SC, Parfitt AM., For whom the bell tolls: osteocyte distress signals and the pathogenesis of metabolic bone diseases. Bone. 2013; 54: 272-8.
57. Lloyd SA, Yuan YY, Kostenuik PJ, Ominsky MS, Lau AG, Morony S, Stolina M, Asuncion FJ, Bateman TA., Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcif Tissue Int. 2008; 82: 361-72.
58. Yuan YY, Kostenuik PJ, Ominsky MS, Morony S, Adamu S, Simionescu DT, Basalyga DM, Asuncion FJ, Bateman TA., Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease. Osteoporos Int. 2008; 19: 625-35.
59. Jilka RL, O'Brien CA, Weinstein RS, Manolagas SC., Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms. J Bone Miner Res. 2010; 25: 2427-37.
60. Jilka RL, Bellido T, Almeida M, Plotkin LI, O'Brien C, Weinstein RS, Manolagas SC., Apoptosis of bone cells. In:, Bilezikian JP, Raisz LG, Martin T, editors. Principles of bone biology 3rd ed. Waltham, MA: Academic Press; p. 235-59. 2008.